Carmel Capital Management L.L.C. Decreases Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Carmel Capital Management L.L.C. reduced its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 28.6% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 25,594 shares of the exchange traded fund’s stock after selling 10,275 shares during the quarter. SPDR S&P Biotech ETF accounts for approximately 0.9% of Carmel Capital Management L.L.C.’s portfolio, making the stock its 23rd largest holding. Carmel Capital Management L.L.C.’s holdings in SPDR S&P Biotech ETF were worth $2,305,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. FMR LLC grew its stake in shares of SPDR S&P Biotech ETF by 13.6% during the 3rd quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock worth $686,000 after acquiring an additional 830 shares during the period. Ameritas Advisory Services LLC lifted its holdings in SPDR S&P Biotech ETF by 11.9% during the fourth quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock valued at $962,000 after purchasing an additional 1,137 shares during the last quarter. Beaton Management Co. Inc. bought a new position in SPDR S&P Biotech ETF during the third quarter worth about $212,000. Robinson Value Management Ltd. increased its stake in shares of SPDR S&P Biotech ETF by 1.2% in the third quarter. Robinson Value Management Ltd. now owns 13,452 shares of the exchange traded fund’s stock worth $1,329,000 after purchasing an additional 155 shares in the last quarter. Finally, Dimension Capital Management LLC raised its position in shares of SPDR S&P Biotech ETF by 28.5% in the second quarter. Dimension Capital Management LLC now owns 15,311 shares of the exchange traded fund’s stock valued at $1,419,000 after purchasing an additional 3,396 shares during the period.

SPDR S&P Biotech ETF Trading Up 1.9 %

Shares of XBI stock opened at $92.98 on Friday. The firm’s 50 day moving average is $93.33 and its 200 day moving average is $96.88. The stock has a market capitalization of $7.09 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.